CORSINI, ALBERTO
CORSINI, ALBERTO
Dipartimento di Scienze Farmacologiche e Biomolecolari
Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer—Evidence from a 17-Year Follow-Up Study
2024 M. Ruscica, C. Macchi, S. Gandini, D. Macis, A. Guerrieri-Gonzaga, V. Aristarco, D. Serrano, M. Lazzeroni, A.S. Rizzuto, A. Gaeta, A. Corsini, M. Gulisano, H. Johansson, B. Bonanni
Low-Density Lipoprotein Cholesterol-Lowering Drugs: A Narrative Review
2024 N. Ferri, M. Ruscica, S. Fazio, A. Corsini
Updates in Small Interfering RNA for the Treatment of Dyslipidemias
2023 S. Carugo, C.R. Sirtori, G. Gelpi, A. Corsini, L. Tokgozoglu, M. Ruscica
PURPL and NEAT1 Long Non-Coding RNAs Are Modulated in Vascular Smooth Muscle Cell Replicative Senescence
2023 C. Rossi, M. Venturin, J. Gubala, A. Frasca, A. Corsini, C. Battaglia, S. Bellosta
Circulating PCSK9 as a prognostic biomarker of cardiovascular events in individuals with type 2 diabetes: evidence from a 16.8-year follow-up study
2023 M. Ruscica, C. Macchi, A. Giuliani, A.S. Rizzuto, D. Ramini, M. Sbriscia, S. Carugo, A.R. Bonfigli, A. Corsini, F. Olivieri, J. Sabbatinelli
Pollution from fine particulate matter and atherosclerosis: A narrative review
2023 C. Macchi, C.R. Sirtori, A. Corsini, P. Mannuccio Mannucci, M. Ruscica
Mechanism of bempedoic acid induced cholelithiasis: A role for statins to limit this adverse effect?
2023 N. Ferri, A. Corsini
Fixed Combination for the Treatment of Dyslipidaemia
2023 N. Ferri, M. Ruscica, R.D. Santos, A. Corsini
Hypocholesterolaemic treatment in coronary unit: from statins to anti PCSK9 therapies and bempedoic acid
2023 N. Ferri, A. Corsini, M. Ruscica
LDL Cholesterol Variability Impacts the Prognosis of Patients with Chronic Ischemic Heart Disease: A Real-World Italian Experience
2023 P. Faggiano, M. Ruscica, S. Bettari, A. Cherubini, S. Carugo, A. Corsini, G. Barbati, A. Di Lenarda
Smooth Muscle Cell Phenotypic Switch Induced by Traditional Cigarette Smoke Condensate: A Holistic Overview
2023 L. Bianchi, I. Damiani, S. Castiglioni, A. Carleo, R. De Salvo, C. Rossi, A. Corsini, S. Bellosta
Beyond statins: New pharmacological targets to decrease LDL-cholesterol and cardiovascular events
2023 E. Raschi, M. Casula, A.F.G. Cicero, A. Corsini, C. Borghi, A. Catapano
OMEGA-3 AND CARDIOVASCULAR PREVENTION - IS THIS STILL A CHOICE?
2022 M. Ruscica, C.R. Sirtori, S. Carugo, P.C. Calder, A. Corsini
PCSK9 Inhibition and Risk of Diabetes: Should We Worry?
2022 S. Carugo, C.R. Sirtori, A. Corsini, L. Tokgozoglu, M. Ruscica
Bempedoic Acid: for Whom and When
2022 M. Ruscica, C.R. Sirtori, S. Carugo, M. Banach, A. Corsini
Side effects of statins-from pathophysiology and epidemiology to diagnostic and therapeutic implications
2022 M. Ruscica, N. Ferri, M. Banach, C.R. Sirtori, A. Corsini
Cholesterol Lowering Biotechnological Strategies: From Monoclonal Antibodies to Antisense Therapies. A Pre-Clinical Perspective Review
2022 S. Bellosta, C. Rossi, A.S. Alieva, A.L. Catapano, A. Corsini, A. Baragetti
LDL-cholesterol control in the primary prevention of cardiovascular diseases: An expert opinion for clinicians and health professionals
2022 A. Poli, A.L. Catapano, A. Corsini, E. Manzato, J.P. Werba, G. Catena, I. Cetin, A.F.G. Cicero, A. Cignarella, F. Colivicchi, A. Consoli, F. Landi, M. Lucarelli, D. Manfellotto, W. Marrocco, D. Parretti, P. Perrone Filardi, A. Pirillo, G. Sesti, M. Volpe, F. Marangoni
PCSK9 Confers Inflammatory Properties to Extracellular Vesicles Released by Vascular Smooth Muscle Cells
2022 M.F. Greco, A.S. Rizzuto, M. Zarà, M. Cafora, C. Favero, G. Solazzo, I. Giusti, M.P. Adorni, F. Zimetti, V. Dolo, C. Banfi, N. Ferri, C.R. Sirtori, A. Corsini, S.S. Barbieri, A. Pistocchi, V. Bollati, C. Macchi, M. Ruscica
Pharmacological rationale for the very early treatment of acute coronary syndrome with monoclonal antibodies anti-PCSK9
2022 N. Ferri, M. Ruscica, M.G. Lupo, M. Vicenzi, C.R. Sirtori, A. Corsini